ES2059805T3 - Compuestos derivados del indano, su procedimiento y los productos intermedios para su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. - Google Patents
Compuestos derivados del indano, su procedimiento y los productos intermedios para su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2059805T3 ES2059805T3 ES89403506T ES89403506T ES2059805T3 ES 2059805 T3 ES2059805 T3 ES 2059805T3 ES 89403506 T ES89403506 T ES 89403506T ES 89403506 T ES89403506 T ES 89403506T ES 2059805 T3 ES2059805 T3 ES 2059805T3
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- medicines
- application
- represent
- indano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 240000001546 Byrsonima crassifolia Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- WGTDLPBPQKAPMN-UHFFFAOYSA-N 2-(2-heptadec-8-enyl-4,5-dihydroimidazol-1-yl)ethanol Chemical compound CCCCCCCCC=CCCCCCCCC1=NCCN1CCO WGTDLPBPQKAPMN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Abstract
LA PETICION TIENE POR OBJETO LOS PRODUCTOS DE FORMULA (I), DONDE R1 Y R2 REPRESENTAN H, ALQUILO O FORMAN JUNTOS UN CICLOALQUILO, EVENTUALMENTE CON UN HETEROATOMO Y, YA R6 Y R7 REPRESENTAN HALOGENO ALQUILO O ALCOXILO, A O B REPRESENTAN UN GRUPO DE FORMULA: (FIG. A) Y EL OTRO A O B REPRESENTA EL GRUPO DE FORMULA: (FIG. B), YA R6 Y R7 REPRESENTAN H, B REPRESENTA PIRROLIDINA Y A N-METIL-3-NITROBENCENOACETAMIDA O 3,5-BIS-(1,1-DIMETILETIL)-4-HIDROXI-N-METILBENZAMIDA O 3,4-DICLORO-N-METIL BENCENOACETAMIDA, O A REPRESENTA 3,4-DICLORO-N-METIL BENCENOACETAMIDA Y B REPRESENTA METIL-(2-FENILETIL)AMINO O (2-FURILMETIL)METILAMINO O 4-(2-METOXIFENIL)-1-PIPERAZINILO, BIEN R6 Y R7 REPRESENTAN UNO H Y EL OTRO CL, B REPRESENTA PIRROLIDINA Y A N-METIL-3-NITRO BENCENOACETAMIDA, BAJO TODAS LAS FORMAS ESTEROISOMERAS, SUS HIDRATOS, SUS SALES, ASI COMO SU OBTENCION Y SU APLICACION COMO MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR888816605A FR2640625B2 (fr) | 1986-08-21 | 1988-12-16 | Nouveaux composes optiquement actifs derives de l'indane, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2059805T3 true ES2059805T3 (es) | 1994-11-16 |
Family
ID=9373020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89403506T Expired - Lifetime ES2059805T3 (es) | 1988-12-16 | 1989-12-15 | Compuestos derivados del indano, su procedimiento y los productos intermedios para su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5436244A (es) |
EP (1) | EP0374054B1 (es) |
JP (1) | JP2753591B2 (es) |
AT (1) | ATE95517T1 (es) |
AU (1) | AU630136B2 (es) |
BG (1) | BG61121B2 (es) |
CA (1) | CA2005626A1 (es) |
DE (1) | DE68909757T2 (es) |
DK (1) | DK626889A (es) |
ES (1) | ES2059805T3 (es) |
HU (2) | HU219446B (es) |
IE (1) | IE65151B1 (es) |
ZA (1) | ZA899616B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
DE19929076A1 (de) | 1999-06-25 | 2000-12-28 | Aventis Pharma Gmbh | Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
CA2983927A1 (en) | 2015-05-06 | 2016-11-10 | The Regents Of The University Of California | K-ras modulators |
GB201601301D0 (en) * | 2016-01-25 | 2016-03-09 | Takeda Pharmaceutical | Novel compounds |
MX2019012532A (es) | 2017-04-20 | 2019-12-02 | Univ California | Moduladores de k-ras. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1109080A (en) * | 1978-05-30 | 1981-09-15 | Hideo Kato | Indanamine derivatives |
US4359476A (en) * | 1981-04-09 | 1982-11-16 | The Upjohn Company | Adjacently substituted cycloalkane-amide analgesics |
US4460600A (en) * | 1981-04-09 | 1984-07-17 | The Upjohn Company | Adjacently substituted ketal derivatives of cycloalkane-amide analgesics |
GB2096607B (en) * | 1981-04-09 | 1985-02-27 | Upjohn Co | Aminocycloalkyl amides |
US4360531A (en) * | 1981-04-09 | 1982-11-23 | The Upjohn Company | Substituted cycloalkanes |
US4466977A (en) * | 1981-04-09 | 1984-08-21 | The Upjohn Company | N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics |
ES2052593T3 (es) * | 1986-08-21 | 1994-07-16 | Roussel Uclaf | Procedimiento para preparar derivados del indano. |
US4876269A (en) * | 1986-09-10 | 1989-10-24 | E. I. Du Pont De Nemours And Company | Benoz-fused cycloalkane trans-1,2-diamine derivatives |
FR2608598B1 (fr) * | 1986-12-23 | 1989-04-14 | Roussel Uclaf | Nouveaux derives de l'indane, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant |
-
1989
- 1989-12-12 DK DK626889A patent/DK626889A/da not_active Application Discontinuation
- 1989-12-14 JP JP1322788A patent/JP2753591B2/ja not_active Expired - Fee Related
- 1989-12-15 ZA ZA899616A patent/ZA899616B/xx unknown
- 1989-12-15 AU AU46802/89A patent/AU630136B2/en not_active Ceased
- 1989-12-15 IE IE402789A patent/IE65151B1/en not_active IP Right Cessation
- 1989-12-15 ES ES89403506T patent/ES2059805T3/es not_active Expired - Lifetime
- 1989-12-15 EP EP89403506A patent/EP0374054B1/fr not_active Expired - Lifetime
- 1989-12-15 AT AT89403506T patent/ATE95517T1/de not_active IP Right Cessation
- 1989-12-15 HU HU631/89A patent/HU219446B/hu not_active IP Right Cessation
- 1989-12-15 DE DE89403506T patent/DE68909757T2/de not_active Expired - Fee Related
- 1989-12-15 CA CA002005626A patent/CA2005626A1/fr not_active Abandoned
-
1993
- 1993-07-22 US US08/096,034 patent/US5436244A/en not_active Expired - Fee Related
-
1994
- 1994-02-23 BG BG98525A patent/BG61121B2/bg unknown
-
1995
- 1995-06-30 HU HU95P/P00668P patent/HU211609A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU896631D0 (en) | 1990-02-28 |
DK626889D0 (da) | 1989-12-12 |
DE68909757D1 (de) | 1993-11-11 |
EP0374054B1 (fr) | 1993-10-06 |
HUT53094A (en) | 1990-09-28 |
DE68909757T2 (de) | 1994-03-31 |
IE65151B1 (en) | 1995-10-04 |
BG61121B1 (bg) | 1996-11-29 |
IE894027L (en) | 1990-06-16 |
ZA899616B (en) | 1991-02-27 |
JP2753591B2 (ja) | 1998-05-20 |
US5436244A (en) | 1995-07-25 |
HU211609A9 (en) | 1995-12-28 |
JPH02218653A (ja) | 1990-08-31 |
AU4680289A (en) | 1990-06-21 |
AU630136B2 (en) | 1992-10-22 |
BG61121B2 (bg) | 1996-11-29 |
CA2005626A1 (fr) | 1990-06-16 |
ATE95517T1 (de) | 1993-10-15 |
HU219446B (hu) | 2001-04-28 |
DK626889A (da) | 1990-06-17 |
EP0374054A1 (fr) | 1990-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR013199A1 (es) | Compuesto sulfonamidas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de los mismos para la fabricacionde un medicamento | |
CO4950558A1 (es) | Moduladores de receptores de aminoacidos excitadores | |
AR015763A1 (es) | Indolinonas sustituidas y sus sales fisiologicamente compatibles, un procedimiento para su preparacion, su empleo para la preparacion de un medicamento, losmedicamentos que las contienen y un procedimiento para la preparacion de estos medicamentos | |
DK0494819T3 (da) | Hidtil ukendte phenylimidazolidiner, deres fremstilling, anvendelse som lægemidler samt farmaceutiske præparater med indhold heraf | |
MX9204661A (es) | Compuestos intermedios derivados de eter y procedimiento para su preparacion. | |
AR005229A1 (es) | Un derivado de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliil y una composicion farmaceutica que lo comprende. | |
ES2116555T3 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2062706T3 (es) | Nuevos derivados de amino-metil-piperidina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2038678T3 (es) | Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos. | |
AR045793A1 (es) | Compuestos derivados de 3-heterociclil-indol | |
ES2036213T3 (es) | Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos. | |
AR007088A1 (es) | 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas | |
ES2059805T3 (es) | Compuestos derivados del indano, su procedimiento y los productos intermedios para su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
CO4810374A1 (es) | Nueva utilizacion de compuestos para actividad anti- pruritica | |
ES2052539T3 (es) | Procedimiento para preparar isoxazolidinas 2,3-disustituidas. | |
AR013608A1 (es) | Derivados de 3,4-diariloxazolona, procedimiento para su preparacion, y composicion farmaceutica que los comprende. | |
AR033350A1 (es) | Acidos (aminopropil) metilfosfinicos, su uso para la manufactura de medicamentos, formulacion farmaceutica, e intermediarios | |
DK616088D0 (da) | Pentamidinsalte, der er nyttige til behandling el ler profylakse af pneumocystis carinii-pneumonia | |
ES2059552T3 (es) | Nuevos imidazo(2,1-b)benzotiazoles y sus sales de adicion con acidos, su procedimiento y los productos intermedios de su preparacion, su aplicacion como medicamentos, y composiciones farmaceuticas que los contienen. | |
ES2108595B1 (es) | Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion. | |
DK0555446T3 (da) | Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors | |
ES2052593T3 (es) | Procedimiento para preparar derivados del indano. | |
DK671588A (da) | Bisphenylalkylpiperazinderivater og fremgangsmaade til fremstilling deraf | |
ES2061162T3 (es) | Compuestos herbicidas. | |
ES2057802T3 (es) | Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 374054 Country of ref document: ES |